Covers exclusive rights to S-pindolol, the novel therapy in development for the treatment of cachexia, in India and South Asia Represents a major step in the mission of Actimed to bring the first globally approved cancer cachexia product to patients in need   Actimed Therapeutics Ltd (“Actimed”), a